About PSM
Consumer Protection Group Issues Statement About FDA’s Ability to Enforce Safety Regulations
Partnership for Safe Medicines Issues Statement About FDA Foreign Drug Inspection Program
Heparin Update: 62 Suspected U.S. Fatalities, 2 Upcoming Hearings
The heparin fallout continues. As an update to our March 13 post, the Food and Drug Administration (FDA) now reports 62, not 19, suspicious deaths in the United States linked to the blood thinner heparin, most of which occurred in December, January and February. According to an article in the New York Times, investigations continue into whether the deaths were caused by the Chinese contaminant.
[...]Federal Efforts to Combat Fake Meds
Partnership for Safe Medicines Echoes Concerns Raised in House Subcommittee Hearing
Bryan A. Liang, MD, PhD, JD
Vice President Bryan A. Liang, Ph.D, M.D., J.D. Professor of Anesthesiology Director, San Diego Center for Patient Safety, University of California San Diego School of Medicine Professor Bryan A. Liang is Professor of Anesthesiology and Director, San Diego Center for Patient Safety, University of California, San Diego School of Medicine as well as Vice President, Partnership for Safe Medicines.…
[...]A Second Article
Take a look at the Safe Medicines Blog.
[...]A Test News Story From About Us
A short blurb about the news story.
[...]Partnership for Safe Medicines Commends New Anti-Counterfeiting Agreement
WASHINGTON, D.C. (Oct. 24, 2007) — The Partnership for Safe Medicines commends yesterday's announcement by the U.S. Trade Representative of a new six-country Anti-Counterfeiting Trade Agreement (ACTA). The purpose of ACTA is to step up enforcement efforts against international counterfeiters.
[...]Shepherd, M.* Drug Importation and Safety of Drugs Obtained from Canada. Ann Pharmacother. 2007;41:1288-1291.
Drug importation from Canada has been hotly debated for nearly a decade. Many believe that drug importation will bring needed competition and lower US drug prices. Opposition argues that the costs of ensuring product quality and safety, as well as added healthcare costs, will offset savings attained from imported pharmaceuticals. The US needs to become…
[...]